Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

Brain tumours reduce life expectancy for an average of 20 years per patient, the highest of any cancer. A third of brain tumour patients visit their GP at least five times before diagnosis and many of those are diagnosed late through emergency departments. A possible solution to this challenge is to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in neurology Ročník 15; s. 1358531
Hlavní autoři: Barber, Hannah R., Perks, Claire M., Kurian, Kathreena M.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland Frontiers Media S.A 28.02.2024
Témata:
blood test
brain tumour
circulating tumour cells
enrichment methods
glioblastoma
liquid biopsy
Neurology
blood test
circulating tumour cells
enrichment methods
glioblastoma
liquid biopsy
brain tumour
ISSN:1664-2295, 1664-2295
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Brain tumours reduce life expectancy for an average of 20 years per patient, the highest of any cancer. A third of brain tumour patients visit their GP at least five times before diagnosis and many of those are diagnosed late through emergency departments. A possible solution to this challenge is to utilise a “liquid biopsy” blood test designed for circulating tumour cells (CTCs). Such a test could be applied at a primary healthcare centre, contributing to informed decision making for diagnostic imaging referrals. Furthermore, it could also be applied at secondary health care centres for the ongoing monitoring of disease recurrence. There is increased interest in CTC enrichment methods as a potential approach for faster diagnosis and monitoring of disease progression. The aim of this review to compare four CTC enrichment methods - OncoQuick ® , Screen Cell ® , pluriBead ® and Cell Search ® – with the objective of identifying a suitable method for application in the clinical setting for the isolation of CTCs from glioblastomas.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Dimitrios N. Kanakis, University of Nicosia, Cyprus
Reviewed by: Andrea Di Cristofori, IRCCS San Gerardo dei Tintori Foundation, Italy
Peter Lin, Cytelligen, United States
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2024.1358531